TESTOSTERONE — all Canadian products
14 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TESTOSTERONE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02245345 | ANDROGEL | BGP PHARMA ULC | Gel | Transdermal | TESTOSTERONE 1 % | Marketed | |
| 02249499 | ANDROGEL | BGP PHARMA ULC | Gel | Transdermal | TESTOSTERONE 12.5 MG | Marketed | |
| 02245346 | ANDROGEL | BGP PHARMA ULC | Gel | Transdermal | TESTOSTERONE 1 % | Marketed | |
| 02450550 | NATESTO | ACERUS BIOPHARMA INC | Gel | Nasal | TESTOSTERONE 4.5 % | Marketed | |
| 02463806 | TARO-TESTOSTERONE GEL | TARO PHARMACEUTICALS INC | Gel | Transdermal | TESTOSTERONE 1 % | Marketed | |
| 02463792 | TARO-TESTOSTERONE GEL | TARO PHARMACEUTICALS INC | Gel | Transdermal | TESTOSTERONE 1 % | Marketed | |
| 02280248 | TESTIM 1% | KNIGHT THERAPEUTICS INC. | Gel | Transdermal | TESTOSTERONE 1 % | Marketed | |
| 02245972 | ANDRODERM | ALLERGAN INC | Patch | Transdermal | TESTOSTERONE 5 MG | Cancelled Post Market | |
| 02239653 | ANDRODERM | ALLERGAN INC | Patch | Transdermal | TESTOSTERONE 2.5 MG | Cancelled Post Market | |
| 02382369 | AXIRON | ELI LILLY CANADA INC | Solution | Transdermal | TESTOSTERONE 30 MG | Cancelled Post Market | |
| 02027046 | MALOGEN AQUEOUS 100 SUS 100MG/ML | GERMIPHENE CORPORATION | Suspension | Intramuscular | TESTOSTERONE 100 MG | Cancelled Post Market | |
| 00477133 | TESTOS 100 INJ 100MG/ML | VETCOM 1979 INC. | Liquid | Intramuscular | TESTOSTERONE 100 MG | Cancelled Post Market | |
| 00616931 | UNI TEST SUSP 100MG/ML | UNIVET PHARMACEUTICALS LTD. | Suspension | Intramuscular | TESTOSTERONE 100 MG | Cancelled Post Market | |
| 02040964 | VETO-TEST (TESTOSTERONE INJECTABLE SUSPENSION) | VETOQUINOL N A INC | Suspension | Intramuscular | TESTOSTERONE 100 MG | Cancelled Post Market |
Browse other molecules: